| # | Drug | Count |
|---|---|---|
| 0 | EXENATIDE | 32 |
| 1 | INSULIN GLARGINE | 19 |
| 2 | METFORMIN | 15 |
| 3 | EMPAGLIFLOZIN | 14 |
| 4 | METFORMIN ER 500 MG | 14 |
| 5 | METFORMIN ER 750 MG | 14 |
| 6 | ASPIRIN | 12 |
| 7 | ASPIRIN 325 MG | 11 |
| 8 | ASPIRIN 81 MG | 11 |
| 9 | GLYBURIDE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PASSIFLORA INCARNATA, IGNATIA AMARA, VALERIANA OFFICINALIS | 1 | 0.0833 |
| 1 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 1 | 0.0009 |
| 2 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 3 | VERTEPORFIN FOR INJECTION | 1 | 0.0007 |
| 4 | AMISULPRIDE | 4 | 0.0007 |
| 5 | CAPIVASERTIB | 2 | 0.0007 |
| 6 | EXENATIDE | 32 | 0.0006 |
| 7 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 2 | 0.0006 |
| 8 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 9 | EMPAGLIFLOZIN AND LINAGLIPTIN | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 32 |
| 1 | Insulin Analog [EPC] | 29 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 18 |
| 3 | Sulfonylurea [EPC] | 18 |
| 4 | Corticosteroid [EPC] | 16 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 12 |
| 7 | Atypical Antipsychotic [EPC] | 10 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 1 | Thymic Stromal Lymphopoietin Blocker [EPC] | 2 | 0.0003 |
| 2 | Photoenhancer [EPC] | 1 | 0.0003 |
| 3 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 7 | 0.0002 |
| 4 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 18 | 0.0002 |
| 5 | Typical Antipsychotic [EPC] | 4 | 0.0002 |
| 6 | Sulfonylurea [EPC] | 18 | 0.0001 |
| 7 | Insulin [EPC] | 6 | 0.0001 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 10 | 0.0001 |
| 9 | GLP-1 Receptor Agonist [EPC] | 32 | 0.0001 |